Evidence map›Paper›PMID 40022072›Full record

ArticleCardiovascular diabetology2025

Comprehensive evaluation of diabetes subtypes in a European cohort reveals stronger differences of lifestyle, education and psychosocial parameters compared to metabolic or inflammatory factors.

Nathalie Rohmann, Johannes Epe, Corinna Geisler, Kristina Schlicht, Kathrin Türk, Katharina Hartmann, Lucy Kruse, Julia Koppenhagen, Ahmad Yusuf Kohestani, Tanja Adam and 5 more

Abstract readComparative Study
In one paragraph

Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nathalie Rohmann *Institute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany.
Johannes Epe *Institute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany.
Corinna GeislerInstitute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany.
Kristina SchlichtInstitute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany.
Kathrin TürkInstitute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany.
Katharina HartmannInstitute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany.
Lucy KruseInstitute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany.
Julia KoppenhagenInstitute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany.
Ahmad Yusuf KohestaniInstitute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany.
Tanja AdamDepartment of Nutrition and Movement Sciences, School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
Corinna BangInstitute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein - Campus Kiel, Kiel, Germany.
Andre FrankeInstitute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein - Campus Kiel, Kiel, Germany.
Dominik M SchulteInstitute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany.
Tim HollsteinInstitute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany.
Matthias LaudesInstitute of Diabetes and Clinical Metabolic Research, University Medical Center Schleswig-Holstein (UKSH) - Campus Kiel, Düsternbrooker Weg 17, 24105, Kiel, Germany. Matthias.Laudes@uksh.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe traditional binary classification of diabetes into Type 1 and Type 2 fails to capture the heterogeneity among diabetes patients. This study aims to identify and characterize diabetes subtypes within the German FoCus cohort, using the ANDIS cohort's classification framework, and to explore subtype-specific variations in metabolic markers, gut microbiota, lifestyle, social factors, and comorbidities.

methodsWe utilized data from 416 participants (208 with diabetes and 208 matched metabolically healthy controls) from the German FoCus cohort. Participants were classified into five subtypes: severe autoimmune diabetes (SAID)-like, severe insulin-deficient diabetes (SIDD)-like, severe insulin-resistant diabetes (SIRD)-like, mild obesity-related diabetes (MOD)-like, and mild age-related diabetes (MARD)-like. Comprehensive characterization included anthropometric measurements, dietary and physical activity questionnaires, blood biomarker analysis, and gut microbiota profiling.

resultsThe subtype distribution in the FoCus cohort accounted to SAID-like: 2.84%, SIDD-like: 30.81%, SIRD-like: 32.23%, MOD-like: 17.54%, MARD-like: 16.59%. Of interest, inflammatory markers (C-reactive protein (CRP) and Interleukin-6 (IL-6)) and glucagon-like peptide-1 (GLP-1) levels were similarly elevated across all subtypes compared to controls, indicating common aspects in Type 2 diabetes molecular pathology despite different clinical phenotypes. While the gut microbiota and dietary patterns only showed minor differences, smoking status, sleep duration, physical activity and psychological aspects varied significantly between the subtypes. In addition, we observed a lower educational status especially for SIDD-like and SIRD-like groups, which should be considered in establishing future diabetes-related patient education programs. In respect to the development of cardio-metabolic comorbidities, we observe not only significant differences in the presence of the diseases but also for their age-of onset, highlighting the need for early preventive intervention strategies.

conclusionsThe study validates the ANDIS classification framework's applicability not only at the time point of manifestation but also in cohorts with pre-existing diabetes. While we did not find major differences regarding the classical metabolic, microbial and nutritional parameters, we identified several significant associations with lifestyle factors. Our findings underscore the importance of personalized, subtype-specific therapies not solely focusing on anthropometric and laboratory markers but comprehensively addressing the patient's own personality and situation of life.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Educational StatusHealth Knowledge, Attitudes, PracticeInflammation MediatorsLife StylePatient Education as TopicAdultAgedBiomarkersCase-Control StudiesComorbidityFemaleGastrointestinal MicrobiomeGermanyHumansBiomarkersInflammation MediatorsDiabetes subtypesDietEducationExerciseGut microbiotaSecondary disease risk

Identifiers

PMID40022072
PMCPMC11871841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.